Relation and developing of central brain activity, cognitive function and fatigue syndrome in pediatric oncology patients in the acute hospital in dependence of the physical activity levels

Not Applicable

• Conditions: Cancer; C00-C97; Malignant neoplasms

• Registration Number: DRKS00010254
• Lead Sponsor: Deutsche Sporthochschule Köln, Institut für Bewegungs- und Neurowissenschaft

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2016-03-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 24

Inclusion Criteria

Patients with an oncological disease (ICD10 C00 - C97), which are located in the inpatient or outpatient treatment in pediatric oncology and hematology of the University of Cologne and received chemotherapeutic treatment.
Gender: Both male and female.
Minimum age: = 6 years.
Maximum age : <16 years .
From the perspective of treating Oncologist exercise is possible.
Presentation of written consent .

Exclusion Criteria

Special stress circumstances (recommendation of the Oncologist).
Severe physical and / or psychological impairments.
Severe chronic illnesses which preclude regular physical activity.
Lack of language comprehension.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Relation and developing of central brain activity (EEG), cognitive function (Oddball-Test) and fatigue syndrome (Peds-QL-multidimensional Fatigue-scale) in pediatric oncology patients in the acute hospital in dependence of the physical activity levels. Patients take part in a computer-based exercise intervention for two month. Results from baseline (T0) should be compared with the results from two month follow-up (T1).

Secondary Outcome Measures

Name	Time	Method
Assessment of the central brain activity (EEG), cognitive function (Oddball-Test) and the fatigue syndrome (Peds-QL-multidimensional Fatigue-scale) in the progress of chemotherapeutic treatment (baseline T0 to follow-up after two month T1).<br><br>Assessment of the central brain activity (EEG), cognitive function (Oddball-Test) and the fatigue syndrome (Peds-QL-multidimensional Fatigue-scale) in a healthy control group and comparing these results with the pediatric oncology patients.